CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Seeking Alpha Healthcare
Original article

Valneva GAAP EPS of -€0.35, revenue of €65.84M; reaffirms FY 2026

EarningsNeutral
AI Analysis

Summary

Valneva reported Q2 2026 GAAP EPS of -€0.35 and revenue of €65.84M, while reaffirming its full-year 2026 guidance.

Financial Highlights

Revenue

€65.84M

EPS

-€0.35

Guidance

FY 2026 reaffirmed

Importance:2/10
Sentiment:
0.00
earningsfinancial_resultsguidance
Related Companies

Read the original article

Published by Seeking Alpha Healthcare on August 13, 2026 6:05 AM

Read Original